# Central Coast Multispecialty Medical Group, Inc. – FDA Inspection, Apr 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/central-coast-multispecialty-medical-group-inc/fd674a5f-5ae9-45ef-a9fd-bbaaedea490c
Source feed: FDA_Inspections

> FDA inspection 1167289 of Central Coast Multispecialty Medical Group, Inc., April 14, 2022. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 1271. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167289
- Company Name: Central Coast Multispecialty Medical Group, Inc.
- Inspection Date: 2022-04-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1270075 - 2025-05-16](https://www.keypedia.com/records/fda_inspections/central-coast-multispecialty-medical-group-inc/5f5e17ef-dab0-4fab-a5b7-86e77d5c2769)
- FDA Inspection 1021255 - 2017-07-31
- FDA Inspection 931419 - 2015-06-23
- [FDA Inspection 805572 - 2012-11-02](https://www.keypedia.com/records/fda_inspections/central-coast-multispecialty-medical-group-inc/41ef21d6-0cc6-4d9d-87c7-be45eba915c9)
- FDA Inspection 681494 - 2010-09-21

Company: https://www.keypedia.com/companies/central-coast-multispecialty-medical-group-inc/d0e71d4d-0178-41e1-9295-f622a41b330a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
